AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

GENETIC SIGNATURES LTD

0.395

+0.0051.28%

Volume:769.00

Turnover:304.00

Market Cap:89.72M

PE:-3.56

High:0.395

Open:0.395

Low:0.395

Close:0.390

Loading ...

Overview Company News Filings

Notification of cessation of securities - GSS-GSS.AX

Change in substantial holding-GSS.AX

ASX April 2025: Highlighting Three Stocks That May Be Trading Below Estimated Value

Simply Wall St.

ASX Stocks That May Be Trading Below Fair Value Estimates In April 2025

Simply Wall St.

Insiders Give Up AU$82k As Genetic Signatures Stock Drops To AU$0.47

Simply Wall St.

ASX Stocks That May Be Trading Below Their Estimated Value In April 2025

Simply Wall St.

We're Interested To See How Genetic Signatures (ASX:GSS) Uses Its Cash Hoard To Grow

Simply Wall St.

Investors in Genetic Signatures (ASX:GSS) from three years ago are still down 51%, even after 16% gain this past week

Simply Wall St.

BRIEF-Genetic Signatures Logs Loss For Half-Year Attributable A$15.2 Mln

Genetic Signatures - Loss for Half-Year Attributable a$15.2 Mln

THOMSON REUTERS

Genetic Signatures - Hy Revenues From Ordinary Activities a$8.5 Mln

THOMSON REUTERS

Investors in Genetic Signatures (ASX:GSS) have unfortunately lost 59% over the last three years

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GSS.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","market":"AU","secType":"STK","nameCN":"GENETIC SIGNATURES LTD","latestPrice":0.395,"timestamp":1752819120000,"preClose":0.39,"halted":0,"volume":769,"delay":0,"nameEN":"GENETIC SIGNATURES LTD","floatShares":188016272,"shares":227142828,"eps":-0.110829,"marketStatus":"Market Closed","change":0.005,"latestTime":"07-18 16:12:00 AEST","open":0.395,"high":0.395,"low":0.395,"amount":304,"amplitude":0,"askPrice":0.4,"askSize":95869,"bidPrice":0.37,"bidSize":29354,"shortable":3,"etf":0,"ttmEps":-0.110829,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1753056000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.39,"openAndCloseTimeList":[[1752796800000,1752818400000]],"volumeRatio":0.007594086688166097,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","floatShares":188016272,"roa":"-20.47%","roe":"-47.52%","lyrEps":-0.108081,"volumeRatio":0.007594086688166097,"shares":227142828,"dividePrice":0,"high":0.395,"amplitude":0,"preClose":0.39,"low":0.395,"week52Low":0.36,"pbRate":"1.64","psRate":"4.81","week52High":0.82,"institutionHeld":0,"latestPrice":0.395,"committee":-0.531172,"eps":-0.110829,"divideRate":0,"volume":769,"delay":0,"ttmEps":-0.110829,"open":0.395,"prevYearClose":0.63,"prevWeekClose":0.365,"prevMonthClose":0.365,"prevQuarterClose":0.365,"fiveDayClose":0.365,"twentyDayClose":0.402,"sixtyDayClose":0.4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSS.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2547313430","title":"Notification of cessation of securities - GSS-GSS.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2547313430","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547313430?lang=en_us&edition=fundamental","pubTime":"2025-06-30 09:08","pubTimestamp":1751245702,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250630:nASX6QTLzt","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nASX1TpSSk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7048","GSS.AU"],"gpt_icon":0},{"id":"2543607623","title":"Change in substantial holding-GSS.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2543607623","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543607623?lang=en_us&edition=fundamental","pubTime":"2025-06-16 14:53","pubTimestamp":1750056839,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250616:nASX3p1Kk6","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nASX5j3NDL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7048","BK7501"],"gpt_icon":0},{"id":"2527422174","title":"ASX April 2025: Highlighting Three Stocks That May Be Trading Below Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2527422174","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527422174?lang=en_us&edition=fundamental","pubTime":"2025-04-16 03:34","pubTimestamp":1744745665,"startTime":"0","endTime":"0","summary":"The Australian market has experienced a relatively stable day, with the ASX200 closing at 7,760 points and sectors such as Health Care showing positive movement while others like Staples lagged. In this context of fluctuating sector performances and strategic shifts among companies, identifying stocks that may be trading below their estimated value can present potential opportunities for investors looking to capitalize on market inefficiencies.Top 10 Undervalued Stocks Based On Cash Flows In Australia. Here we highlight a subset of our preferred stocks from the screener.Overview: Corporate Travel Management Limited is a travel management solutions company that oversees the procurement and delivery of travel services across Australia and New Zealand, North America, Asia, and Europe, with a market cap of A$1.77 billion.Unlock comprehensive insights into our analysis of Corporate Travel Management stock in this financial health report.Overview: Nick Scali Limited, with a market cap of A$1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-april-2025-highlighting-three-193425216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7115","PNR.AU","CTD.AU","BK7088","BK7048","BK7505","PNRDA.AU","BK7124","NCK.AU","GNP.AU","BK7055","BK7117","BK7107","BK7031","XJO.AU","MVP.AU","EOS.AU","XAO.AU","ACF.AU","BK7104","BK7096","IDX.AU","BK7070","BK7501","SHV.AU","3DA.AU","XKO.AU","NXL.AU","GSS.AU","BK7508","BK7016"],"gpt_icon":0},{"id":"2524929058","title":"ASX Stocks That May Be Trading Below Fair Value Estimates In April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524929058","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524929058?lang=en_us&edition=fundamental","pubTime":"2025-04-04 03:05","pubTimestamp":1743707118,"startTime":"0","endTime":"0","summary":"As the Australian market experiences fluctuations, with the ASX200 closing down 0.94% at 7,859.7 points and sectors like IT and Energy leading declines, investors are increasingly focused on identifying stocks that may be trading below their fair value estimates. In such a volatile environment, recognizing undervalued stocks can offer potential opportunities for those looking to capitalize on discrepancies between current market prices and intrinsic value assessments.Top 10 Undervalued Stocks Based On Cash Flows In Australia. Genesis Minerals has shown strong growth, with half-year sales reaching A$338.73 million, up from A$215.92 million the previous year, and net income rising to A$59.8 million. The company updated its 2025 production guidance to 190,000-210,000 oz of gold. Trading at approximately 16.2% below fair value , Genesis is undervalued based on cash flows with earnings projected to grow significantly at over 20% annually for the next three years.GenusPlus Group appears unde","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-stocks-may-trading-below-190518032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7508","XAO.AU","GSS.AU","BK7088","BK7055","EGL.AU","BK7126","PNR.AU","PNV.AU","BK7017","BK7087","BK7120","LOV.AU","NCK.AU","SDV.AU","BK7104","BK7031","BK7128","XJO.AU","CHC.AU","BK7501","ACF.AU","GNP.AU","BK7107","GMD.AU","3DA.AU","XKO.AU","BK7048","NDO.AU"],"gpt_icon":0},{"id":"2524474774","title":"Insiders Give Up AU$82k As Genetic Signatures Stock Drops To AU$0.47","url":"https://stock-news.laohu8.com/highlight/detail?id=2524474774","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524474774?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:51","pubTimestamp":1743627103,"startTime":"0","endTime":"0","summary":"The recent price decline of 16% in Genetic Signatures Limited's ( ASX:GSS ) stock may have disappointed insiders who...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-gss/genetic-signatures-shares/news/insiders-give-up-au82k-as-genetic-signatures-stock-drops-to","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GSS.AU","BK7048","BK7501"],"gpt_icon":0},{"id":"2524442361","title":"ASX Stocks That May Be Trading Below Their Estimated Value In April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524442361","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524442361?lang=en_us&edition=fundamental","pubTime":"2025-04-03 03:04","pubTimestamp":1743620661,"startTime":"0","endTime":"0","summary":"As the ASX200 edges higher, closing up 0.12% at 7,934 points, investors are closely watching sector performances with Real Estate leading the charge and Materials lagging behind. In this mixed market environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for growth and diversification in portfolios.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4300003-choice1-main-header/1585186588101","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4300003-choice1-main-header/1585186588101"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/media/asx-sek/seek-shares/news/asx-stocks-that-may-be-trading-below-their-estimated-value-i-4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IFM.AU","XAO.AU","BK7124","CHC.AU","BK7129","SEK.AU","XJO.AU","BK7120","CIA.AU","BK7503","BK7501","NDO.AU","BK7016","PNR.AU","PNV.AU","BK7048","BK7088","BK7126","GSS.AU","EGL.AU","ACF.AU","SDV.AU","XKO.AU","BK7031","BK7508","BK7087","BK7017","BK7104","IDX.AU","BK7002"],"gpt_icon":0},{"id":"2518303762","title":"We're Interested To See How Genetic Signatures (ASX:GSS) Uses Its Cash Hoard To Grow","url":"https://stock-news.laohu8.com/highlight/detail?id=2518303762","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518303762?lang=en_us&edition=fundamental","pubTime":"2025-03-10 07:47","pubTimestamp":1741564066,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed.So should Genetic Signatures  shareholders be worried about its cash burn?In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.Does Genetic Signatures Have A Long Cash Runway?As you can probably tell by now, we're not too worried about Genetic Signatures' cash burn. For example, we think its cash runway suggests that the company","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/were-interested-see-genetic-signatures-234746038.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["GSS.AU","BK7048","BK7501"],"gpt_icon":0},{"id":"2514846782","title":"Investors in Genetic Signatures (ASX:GSS) from three years ago are still down 51%, even after 16% gain this past week","url":"https://stock-news.laohu8.com/highlight/detail?id=2514846782","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514846782?lang=en_us&edition=fundamental","pubTime":"2025-02-27 07:40","pubTimestamp":1740613246,"startTime":"0","endTime":"0","summary":"This week we saw the Genetic Signatures Limited ( ASX:GSS ) share price climb by 16%. But over the last three years...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-gss/genetic-signatures-shares/news/investors-in-genetic-signatures-asxgss-from-three-years-ago","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7048","BK4211","ISBC","BK7501","GSS.AU"],"gpt_icon":0},{"id":"2514070683","title":"BRIEF-Genetic Signatures Logs Loss For Half-Year Attributable A$15.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514070683","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514070683?lang=en_us&edition=fundamental","pubTime":"2025-02-26 13:38","pubTimestamp":1740548315,"startTime":"0","endTime":"0","summary":"BRIEF-Genetic Signatures Logs Loss For Half-Year Attributable A$15.2 MlnFeb 26 (Reuters) - Genetic Signatures Ltd GSS.AX:LOSS FOR HALF-YEAR ATTRIBUTABLE A$15.2 MILLIONHY REVENUES FROM ORDINARY ACTIVITIES A$8.5 MILLIONFurther company coverage: GSS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PG13N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7501","BK7048"],"gpt_icon":0},{"id":"2514878023","title":"Genetic Signatures - Loss for Half-Year Attributable a$15.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514878023","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514878023?lang=en_us&edition=fundamental","pubTime":"2025-02-26 07:13","pubTimestamp":1740525229,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG13N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GSS.AU","BK7048","BK7501"],"gpt_icon":0},{"id":"2514302387","title":"Genetic Signatures - Hy Revenues From Ordinary Activities a$8.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514302387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514302387?lang=en_us&edition=fundamental","pubTime":"2025-02-26 07:13","pubTimestamp":1740525229,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG13N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7048","GSS.AU"],"gpt_icon":0},{"id":"2510897732","title":"Investors in Genetic Signatures (ASX:GSS) have unfortunately lost 59% over the last three years","url":"https://stock-news.laohu8.com/highlight/detail?id=2510897732","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510897732?lang=en_us&edition=fundamental","pubTime":"2025-02-11 04:35","pubTimestamp":1739219734,"startTime":"0","endTime":"0","summary":"The truth is that if you invest for long enough, you're going to end up with some losing stocks. But the long term shareholders of Genetic Signatures Limited  have had an unfortunate run in the last three years. Unfortunately, they have held through a 60% decline in the share price in that time. Furthermore, it's down 26% in about a quarter. That's not much fun for holders.It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that.ASX:GSS Earnings and Revenue Growth February 10th 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investors-genetic-signatures-asx-gss-203534515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7048","BK4121","ISBC","GSS.AU","GENE","BK4211","BK7501"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSS.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"market":"AU","date":"2023-12-27","symbol":"GSS.AU","defaultRemindTime":1703631600000,"type":"split","dateTimestamp":1703595600000,"forFactor":976761,"toFactor":1000000,"ratio":0.9767610000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSS.AU\",market:\"AU\",,,undefined,":[]}}